New alzheimer’s drug raises hopes – along with questions

A new era of treatment for Alzheimer’s disease has begun with the recent approval of several groundbreaking drugs, notably Leqembi, Aduhelm, and Donanemab. This significant development has sparked both optimism and skepticism within the medical community and beyond. These innovative pharmaceuticals hold the promise of offering much-needed relief to patients grappling with the devastating effects […]

Continue Reading

INDEPENDENCE BLUE CROSS-LED COALITION LAUNCHES TO ELIMINATE RACE-BASED MEDICINE IN PHILADELPHIA REGION

In an era defined by progress and the pursuit of equality, the healthcare sector is undergoing a transformative revolution aimed at dismantling the deeply ingrained biases that have long persisted within its structures. One of the most noteworthy endeavors in this journey is the groundbreaking coalition spearheaded by Independence Blue Cross—a collective of Philadelphia-area health […]

Continue Reading